Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary
Open Access
- 2 May 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 93 (7), 872-878
- https://doi.org/10.1002/bjs.5346
Abstract
Background In many patients with advanced synchronous liver metastases from colorectal tumours, the metastases progress during treatment of the primary, precluding curative treatment. The authors have investigated a management strategy that involves high-impact chemotherapy first, resection of liver metastases second and finally removal of the primary tumour in patients with adverse prognostic factors. Methods Twenty consecutive patients with non-obstructive colonic (nine patients) or rectal (11 patients) cancer and advanced synchronous liver metastases were treated according to this strategy. Median age was 56 years. Patients received between two and six cycles of 5-fluorouracil, oxaliplatin and irinotecan-based chemotherapy. Data were collected prospectively. Results Overall survival rates at 1, 2, 3 and 4 years after the start of treatment were 85, 79, 71 and 56 per cent respectively, with a median survival of 46 months. Sixteen of the 20 patients had complete removal of liver metastases and colorectal tumours (resectability rate 80 per cent). Conclusion This new strategy produced resectability and survival rates better than those expected from the published data on patients with disease of similar severity. It allows initial control and downstaging of liver metastases, and delivery of preoperative radiotherapy for rectal cancer without the fear that liver metastases will meanwhile progress beyond the possibility of cure.Keywords
This publication has 28 references indexed in Scilit:
- Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection ratesAnnals of Oncology, 2005
- Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I–II studyAnnals of Oncology, 2005
- Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal CarcinomaJournal of Clinical Oncology, 2005
- First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly scheduleAnnals of Oncology, 2004
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Surgical strategies for colorectal liver metastasesSurgical Oncology, 2004
- New options and old dilemmas in the treatment of patients with advanced colorectal cancerAnnals of Oncology, 2004
- Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patientsAnnals of Oncology, 2004
- Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liverBritish Journal of Surgery, 2003
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996